A detailed history of Indiana Trust & Investment Management CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Indiana Trust & Investment Management CO holds 25 shares of GILD stock, worth $1,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 25 -0.0%
Holding current value
$1,710
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$73.27 - $83.09 $17,951 - $20,357
-245 Reduced 90.74%
25 $2,000
Q3 2023

Oct 10, 2023

BUY
$73.94 - $80.67 $19,963 - $21,780
270 New
270 $20,000
Q4 2021

Jan 10, 2022

SELL
$64.88 - $73.64 $186,530 - $211,715
-2,875 Closed
0 $0
Q3 2021

Oct 04, 2021

SELL
$67.69 - $73.03 $51,850 - $55,940
-766 Reduced 21.04%
2,875 $201,000
Q2 2021

Jul 07, 2021

BUY
$63.47 - $69.35 $29,450 - $32,178
464 Added 14.6%
3,641 $212,000
Q1 2021

Apr 06, 2021

SELL
$60.0 - $68.46 $27,840 - $31,765
-464 Reduced 12.74%
3,177 $205,000
Q4 2020

Jan 07, 2021

SELL
$56.65 - $64.55 $46,226 - $52,672
-816 Reduced 18.31%
3,641 $212,000
Q3 2020

Oct 06, 2020

SELL
$62.1 - $78.08 $3,415 - $4,294
-55 Reduced 1.22%
4,457 $282,000
Q4 2019

Jan 13, 2020

SELL
$61.62 - $67.78 $75,422 - $82,962
-1,224 Reduced 21.34%
4,512 $293,000
Q3 2019

Oct 04, 2019

SELL
$62.51 - $69.0 $45,632 - $50,370
-730 Reduced 11.29%
5,736 $363,000
Q2 2019

Jul 10, 2019

SELL
$61.87 - $69.38 $184,372 - $206,752
-2,980 Reduced 31.55%
6,466 $437,000
Q1 2019

Apr 08, 2019

BUY
$62.53 - $70.05 $27,825 - $31,172
445 Added 4.94%
9,446 $614,000
Q4 2018

Jan 07, 2019

SELL
$60.54 - $79.0 $39,351 - $51,350
-650 Reduced 6.74%
9,001 $564,000
Q3 2018

Oct 11, 2018

SELL
$71.28 - $78.92 $60,944 - $67,476
-855 Reduced 8.14%
9,651 $745,000
Q2 2018

Jul 06, 2018

SELL
$64.88 - $75.68 $158,307 - $184,659
-2,440 Reduced 18.85%
10,506 $744,000
Q1 2018

Apr 09, 2018

SELL
$72.84 - $88.8 $145 - $177
-2 Reduced 0.02%
12,946 $976,000
Q4 2017

Jan 12, 2018

BUY
$71.15 - $83.52 $1,849 - $2,171
26 Added 0.2%
12,948 $927,000
Q3 2017

Oct 05, 2017

BUY
$72.11 - $85.47 $931,805 - $1.1 Million
12,922
12,922 $1.05 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $85.7B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Indiana Trust & Investment Management CO Portfolio

Follow Indiana Trust & Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indiana Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Indiana Trust & Investment Management CO with notifications on news.